AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 66 filers reported holding AQUESTIVE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 16.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $12,000 | -91.8% | 18,261 | -51.3% | 0.00% | -100.0% |
| Q4 2021 | $146,000 | -45.1% | 37,500 | -26.8% | 0.01% | -46.2% |
| Q1 2021 | $266,000 | +1.5% | 51,200 | +4.5% | 0.01% | +18.2% |
| Q4 2020 | $262,000 | -21.1% | 49,000 | -28.3% | 0.01% | -31.2% |
| Q3 2020 | $332,000 | +163.5% | 68,300 | +163.7% | 0.02% | +166.7% |
| Q2 2020 | $126,000 | +17.8% | 25,900 | +40.8% | 0.01% | +20.0% |
| Q4 2019 | $107,000 | +20.2% | 18,400 | +29.9% | 0.01% | -28.6% |
| Q4 2018 | $89,000 | -80.8% | 14,161 | -46.6% | 0.01% | -80.6% |
| Q3 2018 | $464,000 | – | 26,511 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |